ESTIMATION OF SERUM MAGNESIUM LEVELS AND ITS CORRELATION AMONG PATIENTS WITH DIABETIC RETINOPATHY
DOI:
https://doi.org/10.22159/ijpps.2022v14i10.45762Keywords:
Diabetic retinopathy, Microvascular complications, MagnesiumAbstract
Objective: To find the correlation of serum magnesium levels in diabetic patients with and without retinopathy.
Methods: Hospital Based Cross-Sectional study was conducted on diabetic patients who attend the ophthalmology outpatient department in a medical college and hospital, Puducherry. Patients were divided into two groups with and without diabetic retinopathy. After obtaining institutional ethical committee approval and consent from the patient, anthropometry measurements were taken, followed by the comparison of serum magnesium level estimation in both groups. All parameters are presented as mean±standard deviation (mean±SD). The data was entered and analysed by using Epi info (version 6.04d) software package.
Results: The mean (SD) value of serum magnesium was 1.14 (0.17) and 1.42 (0.15), in cases and controls, respectively. Our results showed that the serum magnesium levels were significantly decreased (p<0.05) among patients with diabetic retinopathy as compared to patients without diabetic retinopathy.
Conclusion: The strong association between serum magnesium levels and severity of type II Diabetes mellitus indicates a role for early prediction and appropriate therapeutic modifications to avoid end-stage disease complications.
Downloads
References
Chauhan DKP, N Haridas DNH, Patel DC. A study of serum magnesium levels in diabetic retinopathy patients. Indian J Appl Res. 2011;3(5):482-4. doi: 10.15373/ 2249555X/MAY2013/151.
Kundu D, Osta M, Mandal T, Bandyopadhyay U, Ray D, Gautam D. Serum magnesium levels in patients with diabetic retinopathy. J Nat Sci Biol Med. 2013;4(1):113-6. doi: 10.4103/0976-9668.107270, PMID 23633845.
Manorma, Mazumder R, Rani A, Budhori R, Kaushik A. Current measures against ophthalmic complications of diabetes mellitus-A short review. Int J App Pharm. 2021;13(6):54-65. doi: 10.22159/ijap.2021v13i6.42876.
S Haddad N, Zuhair S. Serum magnesium and severity of diabetic retinopathy. Med J Basrah Univ. 2010;28(1):36-9. doi: 10.33762/mjbu.2010.49460.
Baig MSA, Ali MS, Tejovathi B. Study of serum magnesium in diabetic retinopathy. Int J Biol Med Res. 2012;3:2480-2.
Nasri H, Baradaran HR. Lipids in association with serum magnesium in diabetes mellitus patients. Bratisl Lek Listy. 2008;109(7):302-6. PMID 18792484.
Tambe B, Phadke V, Kharche S, Joshi R. Correlation of blood pressure with body mass index and waist to hip ratio in middle-aged men. Internet J Med Update. 2010;5:26-30.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560-72. doi: 10.1001/jama.289.19.2560, PMID 12748199.
Xing LY, Diao WL, Liu YQ, Yu LY, Liu L, Li N. Prevalence, awareness, treatment and control of hypertension in rural adult residents of Liaoning Province. Zhonghua Xin Xue Guan Bing Za Zhi. 2010;38(7):652-5. PMID 21055293.
Ceriello A, Giugliano D, Dello Russo P, Passariello N. Hypomagnesemia in relation to diabetic retinopathy. Diabetes Care. 1982;5(5):558-9. doi: 10.2337/diacare.5.5.558, PMID 7188345.
DRK, KMG. A review on role of markers in diabetes mellitus and associated micro and macrovascular complications. Int J Curr Pharm Sci. 2022;14(1):20-6. doi: 10.22159/ ijcpr.2022v14i1.44108.
Durga VS, Premalatha G, Padmavathi K. Correlation of risk factors with severity of diabetic retinopathy. Asian J Pharm Clin Res. 2022 May;15(5):83-5. doi: 10.22159/ ajpcr.2022.v15i5.44431.
Shreen S, Uddin MB, Ali MS, Sultana Z. Prevalence of complications in type 2 diabetes mellitus in a tertiary care hospital-a prospective study. Asian J Pharm Clin Res. 2021 Sep;4(9):153-4. doi: 10.22159/ajpcr.2021.v14i9.42671.
Sakaguchi Y, Shoji T, Hayashi T, Suzuki A, Shimizu M, Mitsumoto K. Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease. Diabetes Care. 2012;35(7):1591-7. doi: 10.2337/dc12-0226. PMID 22498805.
Published
How to Cite
Issue
Section
Copyright (c) 2022 SUMA S., ABEETHA S., DIVYA R.
This work is licensed under a Creative Commons Attribution 4.0 International License.